scispace - formally typeset
R

Richard J. Ulevitch

Researcher at Scripps Research Institute

Publications -  240
Citations -  50508

Richard J. Ulevitch is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: Innate immune system & CD14. The author has an hindex of 102, co-authored 239 publications receiving 49181 citations. Previous affiliations of Richard J. Ulevitch include French Institute of Health and Medical Research & University of Pennsylvania.

Papers
More filters
Patent

Methods for inhibiting cd14 mediated cell activation

TL;DR: In this article, the authors provided hybridoma cell lines producing monoclonal antibodies which inhibit CD14 mediated cell activation, which are useful for the detection of the presence of cell surface and soluble CD14 in a sample.

This information is current as Distinct from That Used by Lipopolysaccharide Monocytic Cells via a CD14-Dependent Pathway Lipoproteins and Synthetic Lipopeptides Activate Borrelia burgdorferi and Treponema pallidum

TL;DR: Gangloff et al. as discussed by the authors cite 72 articles, 54 of which can access for free at: Subscriptionshttp://jimmunol.org/subscriptionsInformation about subscribing to The Journal of Immunology is online at: Permissionshttp://www.aai.jimminol.com/licenses/copyright.htmlSubmit copyright permission requests at: Email Alertshttp://Jimmunool.org /cgi/alerts/etoc

receptors and their transducers

TL;DR: The present review concerns innate immunity: the inherited resistance to infection, shared to some extent by all normal metazoans, and the biochemical details of TLR signaling have been analyzed through forward and reverse genetic methods.